The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kelly Michael Gerald since 2005.
The trader's CIK number is 1278455.
At the time of the last reporting, Kelly Michael Gerald was the VP, Drug Discovery of Renovis Inc. (stock ticker symbol RNVS).
Also see all insider trading activities at Renovis Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2006 | RNVS | 0 | $0 | 8,000 | $166,410 | 0 | $0 |
2005 | RNVS | 0 | $0 | 12,000 | $173,790 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2006-05-16 | RNVS | Sale | 1,000 | 15.70 | 15,700 |
2006-04-17 | RNVS | Sale | 1,000 | 18.65 | 18,650 |
2006-03-16 | RNVS | Sale | 4,000 | 23.38 | 93,520 |
2006-02-16 | RNVS | Sale | 1,000 | 20.36 | 20,360 |
2006-01-17 | RNVS | Sale | 1,000 | 18.18 | 18,180 |
2005-11-17 | RNVS | Sale | 6,000 | 13.96 | 83,790 |
2005-11-15 | RNVS | Sale | 3,000 | 15.00 | 45,000 |
2005-06-24 | RNVS | Sale | 3,000 | 15.00 | 45,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Michael Gerald (VP, Drug Discovery of Renovis Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.